Listed

Caribou Biosciences, Inc.

CRBUNasdaqCIK 1619856HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$1.5m, Q2 FY2026
Operating income−$25.3m, Q2 FY2026
Net income−$24.3m, Q2 FY2026
Caribou Biosciences, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m23.7Revenue, Q3 FY2023, three months to 2023-09-30$23.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-06, accession 0001619856-24-000081.Report this figure3.6Revenue, Q4 FY2023, three months to 2023-12-31$3.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-10, accession 0001619856-25-000015. Derived: 12-month figure less the 9-month figure.Report this figure2.4Revenue, Q1 FY2024, three months to 2024-03-31$2.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-08, accession 0001619856-25-000043.Report this figure3.5Revenue, Q2 FY2024, three months to 2024-06-30$3.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-12, accession 0001619856-25-000061.Report this figure2.0Revenue, Q3 FY2024, three months to 2024-09-30$2.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-12, accession 0001619856-25-000071.Report this figure2.1Revenue, Q4 FY2024, three months to 2024-12-31$2.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-05, accession 0001619856-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure2.4Revenue, Q1 FY2025, three months to 2025-03-31$2.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-07, accession 0001619856-26-000036.Report this figure2.7Revenue, Q2 FY2025, three months to 2025-06-30$2.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001619856-26-000055.Report this figure2.2Revenue, Q3 FY2025, three months to 2025-09-30$2.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-12, accession 0001619856-25-000071.Report this figure3.9Revenue, Q4 FY2025, three months to 2025-12-31$3.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-05, accession 0001619856-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure2.4Revenue, Q1 FY2026, three months to 2026-03-31$2.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-07, accession 0001619856-26-000036.Report this figure1.5Revenue, Q2 FY2026, three months to 2026-06-30$1.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001619856-26-000055.Report this figure
Research and development$m28.6Research and development, Q3 FY2023, three months to 2023-09-30$28.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-06, accession 0001619856-24-000081.Report this figure31.3Research and development, Q4 FY2023, three months to 2023-12-31$31.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-10, accession 0001619856-25-000015. Derived: 12-month figure less the 9-month figure.Report this figure33.8Research and development, Q1 FY2024, three months to 2024-03-31$33.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-08, accession 0001619856-25-000043.Report this figure35.5Research and development, Q2 FY2024, three months to 2024-06-30$35.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-12, accession 0001619856-25-000061.Report this figure30.4Research and development, Q3 FY2024, three months to 2024-09-30$30.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001619856-25-000071.Report this figure30.5Research and development, Q4 FY2024, three months to 2024-12-31$30.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-05, accession 0001619856-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure35.5Research and development, Q1 FY2025, three months to 2025-03-31$35.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001619856-26-000036.Report this figure27.7Research and development, Q2 FY2025, three months to 2025-06-30$27.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-13, accession 0001619856-26-000055.Report this figure22.4Research and development, Q3 FY2025, three months to 2025-09-30$22.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001619856-25-000071.Report this figure23.8Research and development, Q4 FY2025, three months to 2025-12-31$23.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-05, accession 0001619856-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure20.6Research and development, Q1 FY2026, three months to 2026-03-31$20.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001619856-26-000036.Report this figure18.9Research and development, Q2 FY2026, three months to 2026-06-30$18.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-13, accession 0001619856-26-000055.Report this figure
Operating income$m(14.6)Operating income, Q3 FY2023, three months to 2023-09-30−$14.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-06, accession 0001619856-24-000081.Report this figure(37.4)Operating income, Q4 FY2023, three months to 2023-12-31−$37.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-10, accession 0001619856-25-000015. Derived: 12-month figure less the 9-month figure.Report this figure(46.0)Operating income, Q1 FY2024, three months to 2024-03-31−$46.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-08, accession 0001619856-25-000043.Report this figure(43.5)Operating income, Q2 FY2024, three months to 2024-06-30−$43.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-12, accession 0001619856-25-000061.Report this figure(38.2)Operating income, Q3 FY2024, three months to 2024-09-30−$38.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001619856-25-000071.Report this figure(38.9)Operating income, Q4 FY2024, three months to 2024-12-31−$38.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-05, accession 0001619856-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure(42.9)Operating income, Q1 FY2025, three months to 2025-03-31−$42.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001619856-26-000036.Report this figure(47.6)Operating income, Q2 FY2025, three months to 2025-06-30−$47.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001619856-26-000055.Report this figure(29.4)Operating income, Q3 FY2025, three months to 2025-09-30−$29.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001619856-25-000071.Report this figure(28.5)Operating income, Q4 FY2025, three months to 2025-12-31−$28.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-05, accession 0001619856-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure(26.3)Operating income, Q1 FY2026, three months to 2026-03-31−$26.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001619856-26-000036.Report this figure(25.3)Operating income, Q2 FY2026, three months to 2026-06-30−$25.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001619856-26-000055.Report this figure
Interest expense$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Income tax$m0.0Income tax, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-06, accession 0001619856-24-000081.Report this figure0.2Income tax, Q4 FY2023, three months to 2023-12-31$193.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-03-10, accession 0001619856-25-000015. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-08, accession 0001619856-25-000043.Report this figure0.0Income tax, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-08-06, accession 0001619856-24-000064.Report this figure0.0Income tax, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-06, accession 0001619856-24-000081.Report this figure(0.0)Income tax, Q4 FY2024, three months to 2024-12-31−$9.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-05, accession 0001619856-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-08, accession 0001619856-25-000043.Report this figurenot reported0.0Income tax, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-12, accession 0001619856-25-000071.Report this figure(0.6)Income tax, Q4 FY2025, three months to 2025-12-31−$550.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-05, accession 0001619856-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-07, accession 0001619856-26-000036.Report this figurenot reported
Net income$m(10.0)Net income, Q3 FY2023, three months to 2023-09-30−$10.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-06, accession 0001619856-24-000081.Report this figure(34.5)Net income, Q4 FY2023, three months to 2023-12-31−$34.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-10, accession 0001619856-25-000015. Derived: 12-month figure less the 9-month figure.Report this figure(41.2)Net income, Q1 FY2024, three months to 2024-03-31−$41.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001619856-25-000071.Report this figure(37.7)Net income, Q2 FY2024, three months to 2024-06-30−$37.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001619856-25-000071.Report this figure(34.7)Net income, Q3 FY2024, three months to 2024-09-30−$34.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001619856-25-000071.Report this figure(35.5)Net income, Q4 FY2024, three months to 2024-12-31−$35.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-05, accession 0001619856-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure(40.0)Net income, Q1 FY2025, three months to 2025-03-31−$40.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001619856-26-000055.Report this figure(54.1)Net income, Q2 FY2025, three months to 2025-06-30−$54.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001619856-26-000055.Report this figure(27.5)Net income, Q3 FY2025, three months to 2025-09-30−$27.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001619856-25-000071.Report this figure(26.5)Net income, Q4 FY2025, three months to 2025-12-31−$26.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-05, accession 0001619856-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure(25.1)Net income, Q1 FY2026, three months to 2026-03-31−$25.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001619856-26-000055.Report this figure(24.3)Net income, Q2 FY2026, three months to 2026-06-30−$24.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001619856-26-000055.Report this figure
Diluted EPS$ per share(0.12)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.12 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-06, accession 0001619856-24-000081.Report this figurenot reported(0.46)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.46 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-08, accession 0001619856-25-000043.Report this figure(0.42)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.42 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-12, accession 0001619856-25-000061.Report this figure(0.38)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.38 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001619856-25-000071.Report this figurenot reported(0.43)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.43 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001619856-26-000036.Report this figure(0.58)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.58 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001619856-26-000055.Report this figure(0.30)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.30 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001619856-25-000071.Report this figurenot reported(0.26)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.26 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001619856-26-000036.Report this figure(0.24)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.24 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001619856-26-000055.Report this figure
Basic EPS$ per share(0.12)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.12 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-06, accession 0001619856-24-000081.Report this figurenot reported(0.46)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.46 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-08, accession 0001619856-25-000043.Report this figure(0.42)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.42 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-12, accession 0001619856-25-000061.Report this figure(0.38)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.38 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001619856-25-000071.Report this figurenot reported(0.43)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.43 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001619856-26-000036.Report this figure(0.58)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.58 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001619856-26-000055.Report this figure(0.30)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.30 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001619856-25-000071.Report this figurenot reported(0.26)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.26 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001619856-26-000036.Report this figure(0.24)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.24 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001619856-26-000055.Report this figure

Balance sheet

Cash and equivalents$26.2m, Q2 FY2026
Shareholders' equity$98.1m, Q2 FY2026
Caribou Biosciences, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m104Cash and equivalents, Q3 FY2023, at 2023-09-30$104.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-06, accession 0001619856-24-000081.Report this figure51.2Cash and equivalents, FY2023, at 2023-12-31$51.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-10, accession 0001619856-25-000015.Report this figure49.4Cash and equivalents, Q1 FY2024, at 2024-03-31$49.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-08, accession 0001619856-25-000043.Report this figure37.9Cash and equivalents, Q2 FY2024, at 2024-06-30$37.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-12, accession 0001619856-25-000061.Report this figure32.0Cash and equivalents, Q3 FY2024, at 2024-09-30$32.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-12, accession 0001619856-25-000071.Report this figure16.3Cash and equivalents, FY2024, at 2024-12-31$16.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-05, accession 0001619856-26-000008.Report this figure29.4Cash and equivalents, Q1 FY2025, at 2025-03-31$29.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-07, accession 0001619856-26-000036.Report this figure25.2Cash and equivalents, Q2 FY2025, at 2025-06-30$25.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001619856-26-000055.Report this figure11.1Cash and equivalents, Q3 FY2025, at 2025-09-30$11.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-12, accession 0001619856-25-000071.Report this figure12.4Cash and equivalents, FY2025, at 2025-12-31$12.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001619856-26-000055.Report this figure12.1Cash and equivalents, Q1 FY2026, at 2026-03-31$12.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-07, accession 0001619856-26-000036.Report this figure26.2Cash and equivalents, Q2 FY2026, at 2026-06-30$26.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001619856-26-000055.Report this figure
Current assets$m351Current assets, Q3 FY2023, at 2023-09-30$350.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-07, accession 0001619856-23-000124.Report this figure339Current assets, FY2023, at 2023-12-31$338.8m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-10, accession 0001619856-25-000015.Report this figure305Current assets, Q1 FY2024, at 2024-03-31$304.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-07, accession 0001619856-24-000038.Report this figure271Current assets, Q2 FY2024, at 2024-06-30$270.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-06, accession 0001619856-24-000064.Report this figure237Current assets, Q3 FY2024, at 2024-09-30$237.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-06, accession 0001619856-24-000081.Report this figure219Current assets, FY2024, at 2024-12-31$219.4m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-05, accession 0001619856-26-000008.Report this figure217Current assets, Q1 FY2025, at 2025-03-31$217.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-08, accession 0001619856-25-000043.Report this figure193Current assets, Q2 FY2025, at 2025-06-30$192.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-12, accession 0001619856-25-000061.Report this figure156Current assets, Q3 FY2025, at 2025-09-30$155.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-12, accession 0001619856-25-000071.Report this figure145Current assets, FY2025, at 2025-12-31$145.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001619856-26-000055.Report this figure122Current assets, Q1 FY2026, at 2026-03-31$122.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-07, accession 0001619856-26-000036.Report this figure117Current assets, Q2 FY2026, at 2026-06-30$116.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001619856-26-000055.Report this figure
Total assets$m458Total assets, Q3 FY2023, at 2023-09-30$457.5m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-07, accession 0001619856-23-000124.Report this figure432Total assets, FY2023, at 2023-12-31$432.2m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-10, accession 0001619856-25-000015.Report this figure407Total assets, Q1 FY2024, at 2024-03-31$406.8m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-07, accession 0001619856-24-000038.Report this figure373Total assets, Q2 FY2024, at 2024-06-30$372.9m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-06, accession 0001619856-24-000064.Report this figure344Total assets, Q3 FY2024, at 2024-09-30$344.3m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-06, accession 0001619856-24-000081.Report this figure313Total assets, FY2024, at 2024-12-31$313.3m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-05, accession 0001619856-26-000008.Report this figure274Total assets, Q1 FY2025, at 2025-03-31$273.7m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-08, accession 0001619856-25-000043.Report this figure221Total assets, Q2 FY2025, at 2025-06-30$220.9m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-12, accession 0001619856-25-000061.Report this figure195Total assets, Q3 FY2025, at 2025-09-30$195.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-12, accession 0001619856-25-000071.Report this figure175Total assets, FY2025, at 2025-12-31$175.4m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001619856-26-000055.Report this figure149Total assets, Q1 FY2026, at 2026-03-31$149.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-07, accession 0001619856-26-000036.Report this figure143Total assets, Q2 FY2026, at 2026-06-30$142.8m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001619856-26-000055.Report this figure
Current liabilities$m24.6Current liabilities, Q3 FY2023, at 2023-09-30$24.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-07, accession 0001619856-23-000124.Report this figure28.3Current liabilities, FY2023, at 2023-12-31$28.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-10, accession 0001619856-25-000015.Report this figure29.0Current liabilities, Q1 FY2024, at 2024-03-31$29.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-07, accession 0001619856-24-000038.Report this figure30.9Current liabilities, Q2 FY2024, at 2024-06-30$30.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-06, accession 0001619856-24-000064.Report this figure32.2Current liabilities, Q3 FY2024, at 2024-09-30$32.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-06, accession 0001619856-24-000081.Report this figure30.7Current liabilities, FY2024, at 2024-12-31$30.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-05, accession 0001619856-26-000008.Report this figure28.5Current liabilities, Q1 FY2025, at 2025-03-31$28.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-08, accession 0001619856-25-000043.Report this figure28.9Current liabilities, Q2 FY2025, at 2025-06-30$28.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-12, accession 0001619856-25-000061.Report this figure28.1Current liabilities, Q3 FY2025, at 2025-09-30$28.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-12, accession 0001619856-25-000071.Report this figure25.4Current liabilities, FY2025, at 2025-12-31$25.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001619856-26-000055.Report this figure19.7Current liabilities, Q1 FY2026, at 2026-03-31$19.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-07, accession 0001619856-26-000036.Report this figure18.0Current liabilities, Q2 FY2026, at 2026-06-30$18.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001619856-26-000055.Report this figure
Total liabilities$m59.3Total liabilities, Q3 FY2023, at 2023-09-30$59.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-07, accession 0001619856-23-000124.Report this figure63.8Total liabilities, FY2023, at 2023-12-31$63.8m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-10, accession 0001619856-25-000015.Report this figure63.5Total liabilities, Q1 FY2024, at 2024-03-31$63.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-07, accession 0001619856-24-000038.Report this figure62.5Total liabilities, Q2 FY2024, at 2024-06-30$62.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-06, accession 0001619856-24-000064.Report this figure63.1Total liabilities, Q3 FY2024, at 2024-09-30$63.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-06, accession 0001619856-24-000081.Report this figure60.4Total liabilities, FY2024, at 2024-12-31$60.4m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-05, accession 0001619856-26-000008.Report this figure56.4Total liabilities, Q1 FY2025, at 2025-03-31$56.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-08, accession 0001619856-25-000043.Report this figure54.8Total liabilities, Q2 FY2025, at 2025-06-30$54.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-12, accession 0001619856-25-000061.Report this figure53.1Total liabilities, Q3 FY2025, at 2025-09-30$53.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-12, accession 0001619856-25-000071.Report this figure53.2Total liabilities, FY2025, at 2025-12-31$53.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0001619856-26-000055.Report this figure47.0Total liabilities, Q1 FY2026, at 2026-03-31$47.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-07, accession 0001619856-26-000036.Report this figure44.7Total liabilities, Q2 FY2026, at 2026-06-30$44.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0001619856-26-000055.Report this figure
Shareholders' equity$m398Shareholders' equity, Q3 FY2023, at 2023-09-30$398.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-06, accession 0001619856-24-000081.Report this figure368Shareholders' equity, FY2023, at 2023-12-31$368.4m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-05, accession 0001619856-26-000008.Report this figure343Shareholders' equity, Q1 FY2024, at 2024-03-31$343.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001619856-25-000071.Report this figure310Shareholders' equity, Q2 FY2024, at 2024-06-30$310.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001619856-25-000071.Report this figure281Shareholders' equity, Q3 FY2024, at 2024-09-30$281.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001619856-25-000071.Report this figure253Shareholders' equity, FY2024, at 2024-12-31$253.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001619856-26-000055.Report this figure217Shareholders' equity, Q1 FY2025, at 2025-03-31$217.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001619856-26-000055.Report this figure166Shareholders' equity, Q2 FY2025, at 2025-06-30$166.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001619856-26-000055.Report this figure142Shareholders' equity, Q3 FY2025, at 2025-09-30$141.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001619856-25-000071.Report this figure122Shareholders' equity, FY2025, at 2025-12-31$122.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001619856-26-000055.Report this figure102Shareholders' equity, Q1 FY2026, at 2026-03-31$102.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001619856-26-000055.Report this figure98.1Shareholders' equity, Q2 FY2026, at 2026-06-30$98.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001619856-26-000055.Report this figure

Cash flow

Operating cash flow−$22.8m, Q2 FY2026
Capital expenditure$1.0k, Q2 FY2026
Caribou Biosciences, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(28.8)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$28.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-06, accession 0001619856-24-000081. Derived: 9-month figure less the 6-month figure.Report this figure(21.4)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$21.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-10, accession 0001619856-25-000015. Derived: 12-month figure less the 9-month figure.Report this figure(37.2)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$37.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-08, accession 0001619856-25-000043.Report this figure(32.9)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$32.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-12, accession 0001619856-25-000061. Derived: 6-month figure less the 3-month figure.Report this figure(32.7)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$32.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001619856-25-000071. Derived: 9-month figure less the 6-month figure.Report this figure(35.5)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$35.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-05, accession 0001619856-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure(36.7)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$36.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001619856-26-000036.Report this figure(28.3)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$28.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001619856-26-000055. Derived: 6-month figure less the 3-month figure.Report this figure(25.2)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$25.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001619856-25-000071. Derived: 9-month figure less the 6-month figure.Report this figure(20.8)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$20.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-05, accession 0001619856-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure(27.0)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$27.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001619856-26-000036.Report this figure(22.8)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$22.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001619856-26-000055. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m4.8Capital expenditure, Q3 FY2023, three months to 2023-09-30$4.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-06, accession 0001619856-24-000081. Derived: 9-month figure less the 6-month figure.Report this figure2.3Capital expenditure, Q4 FY2023, three months to 2023-12-31$2.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-10, accession 0001619856-25-000015. Derived: 12-month figure less the 9-month figure.Report this figure1.4Capital expenditure, Q1 FY2024, three months to 2024-03-31$1.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-08, accession 0001619856-25-000043.Report this figure2.2Capital expenditure, Q2 FY2024, three months to 2024-06-30$2.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-12, accession 0001619856-25-000061. Derived: 6-month figure less the 3-month figure.Report this figure0.7Capital expenditure, Q3 FY2024, three months to 2024-09-30$673.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-12, accession 0001619856-25-000071. Derived: 9-month figure less the 6-month figure.Report this figure0.5Capital expenditure, Q4 FY2024, three months to 2024-12-31$518.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-05, accession 0001619856-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure1.0Capital expenditure, Q1 FY2025, three months to 2025-03-31$1.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-07, accession 0001619856-26-000036.Report this figure0.4Capital expenditure, Q2 FY2025, three months to 2025-06-30$418.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-13, accession 0001619856-26-000055. Derived: 6-month figure less the 3-month figure.Report this figure0.1Capital expenditure, Q3 FY2025, three months to 2025-09-30$115.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-12, accession 0001619856-25-000071. Derived: 9-month figure less the 6-month figure.Report this figure(0.2)Capital expenditure, Q4 FY2025, three months to 2025-12-31−$216.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-05, accession 0001619856-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure0.1Capital expenditure, Q1 FY2026, three months to 2026-03-31$72.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-07, accession 0001619856-26-000036.Report this figure0.0Capital expenditure, Q2 FY2026, three months to 2026-06-30$1.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-13, accession 0001619856-26-000055. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)100.99m, Q2 FY2026
Caribou Biosciences, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares60.9Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3060,886,921 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-07, accession 0001619856-23-000124.Report this figure61.2Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3161,186,514 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-07, accession 0001619856-24-000038.Report this figure61.4Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3061,417,934 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-06, accession 0001619856-24-000064.Report this figure83.8Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3083,783,992 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-06, accession 0001619856-24-000081.Report this figure89.3Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3189,302,937 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-08, accession 0001619856-25-000043.Report this figure90.3Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3090,340,932 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-12, accession 0001619856-25-000061.Report this figure90.5Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3090,455,900 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-12, accession 0001619856-25-000071.Report this figure92.7Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3192,679,493 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001619856-26-000036.Report this figure93.0Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3093,028,698 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-13, accession 0001619856-26-000055.Report this figure93.3Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3093,293,099 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-12, accession 0001619856-25-000071.Report this figure95.9Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3195,861,716 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001619856-26-000036.Report this figure101Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30100,985,698 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-13, accession 0001619856-26-000055.Report this figure

Shares outstanding: 107.21mShares outstanding, period not labelled, at 2026-08-07107,207,513 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-13, accession 0001619856-26-000055.Report this figure at Aug 7, 2026, from the cover of the 10-Q filed Aug 13, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:44 ET. Listed shows no prices and gives no investment advice.